Article Text

Download PDFPDF

18 Upgrade to defibrillator in patients receiving cardiac resynchronisation therapy pacemakers
  1. Shveta Monga1,
  2. Dominic Haigh1,
  3. David Royan1,
  4. Paul Foley1,
  5. Badrinath Chandrasekaran1
  1. 1Great Western hospital NHS trust


Introduction In patients with advanced cardiac failure, the choice between CRT with (CRT-D) or without a defibrillator (CRT-P), remains a contentious issue. There is insufficient evidence from randomised controlled trials and guidelines do not make any firm recommendations. This leaves room for physician discretion and has led to wide variation in worldwide practice.

Study aim and basic methods The focus of our study was to evaluate the characteristics of CRT-P patients in the real world setting and analyse how many patients with CRT-P implant required an upgrade to CRT-D in the follow-up period.

This was a retrospective single centre observational study looking at 122 patients implanted with CRT from 2011 to 2015. Data was collected from patient electronic records and follow-up visits. The median follow-up duration was 2.2 (1.2–3.3) years. Data was analysed using Microsoft excel and SPSS.

Results 1. The patients implanted with CRT-P were elderly, had more advanced heart failure with multiple co-morbidities and mostly females.

2. Only 3 out of 122 patients (2.5%) were upgraded from CRT-P to CRT-D. All these patients were males, above 75 years of age with a primary prevention indication for CRT-D and had upgrade following episodes of symptomatic ventricular tachycardia (Figure 1).

Abstract 18 Figure 1

Clinical profile of upgraded patients compared to rest of the CRT-P population

3. The main cause of mortality in patients implanted with CRT-P was non-cardiac vs. cardiac (5.7% vs. 15.6%, p value<0.001). Majority of deaths in the cardiac group were due to pump failure. Only 10% of patients in this group had documented non sustained ventricular arrhythmias.

Conclusion In our study population, the number of CRT-P patients who needed upgrade with additional defibrillator was surprisingly small in medium term follow up. This implies that clinician guided selection criteria is an appropriate method of selecting patients who may not derive additional benefit from a defibrillator.

  • Cardiac Resynchronisation Therapy
  • Heart Failure
  • Devices

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.